Literature DB >> 24908061

A single nucleotide polymorphism in PIK3CA gene is inversely associated with P53 protein expression in breast cancer.

Bo Pang1, Shi-Peng Sun, Lei Gao, Rui-Li Zhu, Li-xin Zhang, Cheng An, Zhi-Yuan Liu, Gui-Jian Liu.   

Abstract

Single nucleotide polymorphism (SNP) rs17849071 was recently reported to be inversely associated with PIK3CA amplification in follicular thyroid cancer, but the main function of this SNP remains unclear. In this study, by using PCR and sequencing method, we explored whether this SNP was associated with P53 expression status and other clinicopathological characteristics in 62 Chinese breast cancer (BCa) patients. In our results, P53 protein accumulation was significantly associated with HER2 overexpression (P = 0.013) and Ki-67 expression (P = 0.007), which were in accord with previous studies. Besides, there was a significantly inverse relationship between P53 protein expression and rs17849071 GT+GG genotype in Chinese BCa patients (P = 0.044). The SNP was not related to other important BCa markers such as estrogen receptor, progestin receptor, and HER2. Among different BCa intrinsic subtypes, no significant differences were found on P53 expression status (P = 0.356) or rs17849071 polymorphism (T>G) (P = 0.813). In conclusion, SNP rs17849071 GT+GG genotype was inversely associated with P53 protein accumulation in BCa samples. Studies with larger sample size focusing on exploring the relationship of rs17849071 polymorphisms, P53 accumulation, P53 mutations, and PIK3CA amplification might be needed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24908061     DOI: 10.1007/s12032-014-0030-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  31 in total

1.  p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study.

Authors:  Thomas E Rohan; Shu-Qiu Li; Robert Hartwick; Rita A Kandel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

2.  PIK3CA as an oncogene in cervical cancer.

Authors:  Y Y Ma; S J Wei; Y C Lin; J C Lung; T C Chang; J Whang-Peng; J M Liu; D M Yang; W K Yang; C Y Shen
Journal:  Oncogene       Date:  2000-05-25       Impact factor: 9.867

3.  Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer.

Authors:  Snehal M Gaikwad; Pritha Ray
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

4.  Value of epidermal growth factor receptor, HER2, p53, and steroid receptors in predicting the efficacy of tamoxifen in high-risk postmenopausal breast cancer patients.

Authors:  A S Knoop; S M Bentzen; M M Nielsen; B B Rasmussen; C Rose
Journal:  J Clin Oncol       Date:  2001-07-15       Impact factor: 44.544

5.  PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas.

Authors:  Jong Woo Lee; Young Hwa Soung; Su Young Kim; Hae Woo Lee; Won Sang Park; Suk Woo Nam; Sang Ho Kim; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
Journal:  Oncogene       Date:  2005-02-17       Impact factor: 9.867

6.  Mutation of the PIK3CA gene in ovarian and breast cancer.

Authors:  Ian G Campbell; Sarah E Russell; David Y H Choong; Karen G Montgomery; Marianne L Ciavarella; Christine S F Hooi; Briony E Cristiano; Richard B Pearson; Wayne A Phillips
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

7.  HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.

Authors:  D A Berry; H B Muss; A D Thor; L Dressler; E T Liu; G Broadwater; D R Budman; I C Henderson; M Barcos; D Hayes; L Norton
Journal:  J Clin Oncol       Date:  2000-10-15       Impact factor: 44.544

8.  Mechanisms underlying p53 regulation of PIK3CA transcription in ovarian surface epithelium and in ovarian cancer.

Authors:  Arezoo Astanehe; David Arenillas; Wyeth W Wasserman; Peter C K Leung; Sandra E Dunn; Barry R Davies; Gordon B Mills; Nelly Auersperg
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

9.  Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy.

Authors:  Hee Sung Kim; Cha Kyong Yom; Hee Jeong Kim; Jong Won Lee; Jin Hee Sohn; Jun Ho Kim; Yong Lai Park; Sei Hyun Ahn
Journal:  Breast Cancer Res Treat       Date:  2009-10-06       Impact factor: 4.872

10.  PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.

Authors:  Iwona K Kolasa; Alina Rembiszewska; Anna Felisiak; Izabela Ziolkowska-Seta; Magdalena Murawska; Joanna Moes; Agnieszka Timorek; Agnieszka Dansonka-Mieszkowska; Jolanta Kupryjanczyk
Journal:  Cancer Biol Ther       Date:  2009-01-17       Impact factor: 4.742

View more
  3 in total

1.  Genetic association between PIK3CA gene and oral squamous cell carcinoma: a case control study conducted in Chongqing, China.

Authors:  Xiaoxiao Wan; Xian Li; Junyan Yang; Wei Lv; Qiming Wang; Ying Chen; Yong Li
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Interleukin-16 polymorphisms as new promising biomarkers for risk of gastric cancer.

Authors:  Seyed Mohammad Hossein Kashfi; Faegheh Behboudi Farahbakhsh; Ehsan Nazemalhosseini Mojarad; Kazem Mashayekhi; Pedram Azimzadeh; Sara Romani; Shaghayegh Derakhshani; Habib Malekpour; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Tumour Biol       Date:  2015-09-07

3.  Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients.

Authors:  Francesca Morgese; Davide Soldato; Silvia Pagliaretta; Riccardo Giampieri; Donatella Brancorsini; Mariangela Torniai; Silvia Rinaldi; Agnese Savini; Azzurra Onofri; Marina Scarpelli; Rossana Berardi
Journal:  Oncotarget       Date:  2017-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.